BIOTYPE GmbH is an innovative German provider of molecular precision diagnostics focused on advancing precision medicine through reliable biomarker testing solutions. The company offers a comprehensive portfolio for hemato-oncology, liquid biopsy, molecular profiling of solid tumors, and chimerism monitoring, serving both clinical diagnostics and translational research applications. BIOTYPE is also known for its proprietary MODAPLEX® platform, which enables automated multi-biomarker analysis and same-day molecular testing results.
